Nobel Biocare Holding AG (Nobel Biocare Holding AG) Change In Working Capital : $-12.0 Mil (TTM As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Change In Working Capital?

Nobel Biocare Holding AG's change in working capital for the quarter that ended in Dec. 2013 was $-12.0 Mil.

Nobel Biocare Holding AG's change in working capital for the fiscal year that ended in Dec. 2013 was $-12.0 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Nobel Biocare Holding AG Change In Working Capital Historical Data

The historical data trend for Nobel Biocare Holding AG's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Change In Working Capital Chart

Nobel Biocare Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Change In Working Capital

Get a 7-Day Free Trial

38.11

22.41

26.54

19.63

-12.01

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Change In Working Capital	Get a 7-Day Free Trial							38.11	22.41	26.54	19.63	-12.01

Nobel Biocare Holding AG Change In Working Capital Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2013 was $-12.0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Nobel Biocare Holding AG Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nobelbiocare.com

Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014